Related Experiment Video
Updated: Jan 16, 2026

07:25
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
2.5K
Five-Gene Expression Formula Accurately Detects Hepatocellular Carcinoma Tumors
Arxiv
|September 29, 2025
Summary
A new predictive formula using five genes (VIPR1, CYP1A2, FCN3, ECM1, LIFR) shows high accuracy for early hepatocellular carcinoma (HCC) detection. This approach offers a simple, interpretable, and efficient method for identifying liver cancer.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Hepatocellular carcinoma (HCC) is a major global cause of cancer mortality.
- Current diagnostic methods like imaging and Alpha-Fetoprotein (AFP) testing are limited to later disease stages.
- Transcriptomic analysis offers potential for early HCC detection, but machine learning applications face challenges in generalizability, interpretability, and complexity.
Purpose of the Study:
- To develop a novel, interpretable, and efficient predictive formula for early hepatocellular carcinoma (HCC) detection.
- To address the limitations of existing machine learning approaches in transcriptomic data analysis for cancer detection.
Main Methods:
- Utilized the Kolmogorov-Arnold Network (KAN) to create a predictive formula for HCC detection.
- The formula is based on the expression levels of five specific genes: VIPR1, CYP1A2, FCN3, ECM1, and LIFR.
- The model was trained on the GSE25097 dataset and validated on six independent datasets.
Main Results:
- The developed KAN-based formula achieved 99% accuracy on the GSE25097 test set.
- The formula demonstrated robust performance across six independent datasets, with accuracies consistently above 90%.
- Identified VIPR1, CYP1A2, FCN3, ECM1, and LIFR as critical gene biomarkers for HCC detection.
Conclusions:
- The novel KAN-based predictive formula provides a simple, interpretable, and efficient approach for early HCC identification.
- The identified five genes serve as promising biomarkers for improving HCC diagnostic strategies.
- This research lays the groundwork for future clinical applications to enhance early liver cancer detection and management.

